HEPACAN

2024

1. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis

   JHEP Reports, Vol. 6, Núm. 8

2. Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression

   Journal of Physiology and Biochemistry

3. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

   Gut

4. New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study

   Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5

5. Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)

   Clinical science (London, England : 1979), Vol. 138, Núm. 20, pp. 1265-1284

6. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

   Gastroenterologia y Hepatologia

7. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

   Clinical and Molecular Hepatology, Vol. 30, Núm. 2, pp. 177-190

8. When you eat and when you sleep matters: Circadian dysfunction revealed as a direct hepatic carcinogen in a humanized mouse model

   Journal of Hepatology